Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07535294 · ClinicalTrials.gov registry record · NA
Assess Patient Readiness for Pelvic Ultrasound With the Use of Artificial Intelligence
A NA study, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 520
- Enrollment target
NCT07535294: Completed NA study, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
NCT07535294 is a NA study that has completed, run by Nicklaus Children's Hospital f/k/a Miami Children's Hospital. The registered enrollment target is 520 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07535294, a NA study, has completed, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 520 participants
- Enrollment target
Study Summary
Point-of-Care Ultrasound (POCUS) is a relatively quick and non-invasive technique to assess bladder fullness which will be provided under standard of care. The goal of this study is to assess for bladder fullness by measuring bladder volume using a handheld POCUS with AI technology to objectively determine patient readiness for pelvic ultrasound.
Primary Outcome
This study aims to determine whether AI-POCUS assessment of bladder volume can expedite transabdominal pelvic ultrasound. The primary objective is time to transabdominal pelvic ultrasound (calculated from time the ultrasound was ordered to when the ultrasound was started in Radiology).
Interventions
- OTHER Experimental AI POCUS
- DIAGNOSTIC_TEST Standard of Care Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2024-08-14 |
| Est. Completion | 2026-02-11 |
| Phase | NA |
What the finished NCT07535294 record still lists
NCT07535294 is an interventional study that assigns participants to a tested intervention. The registered 520 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental AI POCUS is the first listed.
NCT07535294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07535294 about?
NCT07535294 is a clinical study titled "Assess Patient Readiness for Pelvic Ultrasound With the Use of Artificial Intelligence". Point-of-Care Ultrasound (POCUS) is a relatively quick and non-invasive technique to assess bladder fullness which will be provided under standard of care. The goal of this study is to assess for bladder fullness by measuring bladder volume using a handheld POCUS with AI technology to objectively de...
What is the current status of trial NCT07535294?
This trial is currently completed. It is a NA study. The enrollment target is 520 participants. The study started on 2024-08-14. Estimated completion is 2026-02-11.
What interventions are being tested in trial NCT07535294?
The interventions under investigation include: Experimental AI POCUS (OTHER), Standard of Care Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07535294?
This trial is sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07535294's enrollment target sits among peer trials
520 190th of 2000 higher than 1,810 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
- NCT05445778 · 520 participants · Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- NCT05498428 · 520 participants · Phase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI